Debbie van Baarle

7.7k citations

131 papers · 4.2k indexed · 2 hit papers · h-index 33

Co-authors: Frank Miedema Stefan Kostense Nening M. Nanlohy M. Shirin Sabbaghian Stephen A. Migueles Mark Connors Ronald L. Rabin Linda A. Ehler
Topics: Immune Cell Function and Interaction (53 papers)HIV Research and Treatment (34 papers)Cytomegalovirus and herpesvirus research (34 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: New England Journal of Medicine Nature Communications Blood
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Debbie van Baarle

121 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

2002 792 citations Debbie van Baarle, Frank Miedema et al. profile →
Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life

2019 289 citations Debbie van Baarle et al. Nature Communications profile →

Peers

Countries citing papers authored by Debbie van Baarle

Since Specialization

Citations

This map shows the geographic impact of Debbie van Baarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie van Baarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie van Baarle more than expected).

Fields of papers citing papers by Debbie van Baarle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie van Baarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie van Baarle. The network helps show where Debbie van Baarle may publish in the future.

Co-authorship network of co-authors of Debbie van Baarle

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie van Baarle. A scholar is included among the top collaborators of Debbie van Baarle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie van Baarle. Debbie van Baarle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals 2025 ·The Journal of Immunology ·Thomas Schenk,Martijn Vos,Yannick van Sleen,(unknown),Debbie van Baarle,Teun Guichelaar	0
2	Re-evaluating CD57 as a marker of T cell senescence: implications for immune ageing and differentiation 2025 ·Immunity & Ageing ·Gaëlle Autaa,Daniil Korenkov,Josine van Beek,Isabelle Pellegrin,Béatrice Parfait,Debbie van Baarle,Odile Launay,Éric Tartour,Victor Appay	0
3	Effects of ageing and frailty on circulating monocyte and dendritic cell subsets 2024 ·PubMed ·(unknown),Ashok Kumar Kumawat,(unknown),Debbie van Baarle,Yannick van Sleen	11
4	mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy 2024 ·Frontiers in Immunology ·Anastasia Gangaev,Yannick van Sleen,(unknown),(unknown),(unknown),(unknown),Annemarie Boerma,Marieke van der Heiden,Sjoukje F. Oosting,Astrid A.M. van der Veldt,T. Jeroen N. Hiltermann,Corine H. GeurtsvanKessel,Anne‐Marie C. Dingemans,Egbert F. Smit,Elisabeth G.E. de Vries,John B.A.G. Haanen,Pia Kvistborg,Debbie van Baarle	2
5	Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial 2024 ·Nature Communications ·Marieke van der Heiden,Sudarshan A. Shetty,(unknown),(unknown),(unknown),Yannick van Sleen,Irina Tcherniaeva,(unknown),Wivine Burny,Rob van Binnendijk,(unknown),(unknown),Nynke Y. Rots,Josine van Beek,Debbie van Baarle	6
6	Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge 2023 ·npj Vaccines ·(unknown),(unknown),Harry van Dijken,(unknown),(unknown),(unknown),Paul Roholl,José A. M. Borghans,Debbie van Baarle,Jørgen de Jonge	2
7	On the feasibility of using TCR sequencing to follow a vaccination response – lessons learned 2023 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),(unknown),Martijn Vos,José A. M. Borghans,Debbie van Baarle,Rob J. de Boer	0
8	A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets 2022 ·Science Advances ·(unknown),(unknown),Harry van Dijken,Hiromi Muramatsu,(unknown),(unknown),(unknown),Mitchell Beattie,Paulo J.C. Lin,José A. Ferreira,Judith M. A. van den Brand,Debbie van Baarle,Norbert Pardi,Jørgen de Jonge	27
9	High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients 2022 ·The Journal of Heart and Lung Transplantation ·Rogier A.S. Hoek,Erik A.M. Verschuuren,Rory D. de Vries,Judith M. Vonk,Debbie van Baarle,Marieke van der Heiden,(unknown),(unknown),Hubert G.M. Niesters,Michiel E. Erasmus,Merel E. Hellemons,Sandra Scherbeijn,(unknown),Edris A.F. Mahtab,Corine H. GeurtsvanKessel,Coretta van Leer‐Buter	20
10	Quantification of T-cell dynamics during latent cytomegalovirus infection in humans 2021 ·PLoS Pathogens ·(unknown),(unknown),Julia Drylewicz,Nening M. Nanlohy,(unknown),(unknown),(unknown),Martijn Vos,Sigrid A. Otto,Rob J. de Boer,Kiki Tesselaar,José A. M. Borghans,Debbie van Baarle	24
11	Sickness absenteeism, work performance, and healthcare use due to respiratory infections for shift and non-shift workers 2020 ·Chronobiology International ·(unknown),Bette Loef,Allard J. van der Beek,Debbie van Baarle,Karin I. Proper	5
12	333 HCV-INFECTION IS NOT A MAJOR DETERMINANT OF IMMUNESENESCENCE IN AGING DRUG USERS 2013 ·Journal of Hepatology ·Bart Grady,Nening M. Nanlohy,Jan M. Prins,Debbie van Baarle	0
13	Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection 2007 ·The Journal of Immunology ·Marjon Navis,Ingrid M. M. Schellens,Debbie van Baarle,José A. M. Borghans,Peter van Swieten,Frank Miedema,Neeltje A. Kootstra,Hanneke Schuitemaker	73
14	Differential Usage of Cellular Niches by Cytomegalovirus versus EBV- and Influenza Virus-Specific CD8+ T Cells 2006 ·The Journal of Immunology ·Ester M. M. van Leeuwen,Jasper J. Koning,Ester B. M. Remmerswaal,Debbie van Baarle,René A. W. van Lier,Ineke J. M. ten Berge	37
15	Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient 2006 ·Clinical Immunology ·Erwan Piriou,Karel van Dort,Jan Weel,Fréderike J. Bemelman,Laila E. Gamadia,Marinus H. J. van Oers,Debbie van Baarle	6
16	T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani 2005 ·Clinical Immunology ·Asrat Hailu,Debbie van Baarle,(unknown),Nega Berhe,Frank Miedema,Piet A. Kager	63
17	Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy 2005 ·The Journal of Immunology ·Erwan Piriou,Christine A. Jansen,Karel van Dort,Iris M. De Cuyper,Nening M. Nanlohy,Joep M. A. Lange,Marinus H. J. van Oers,Frank Miedema,Debbie van Baarle	23
18	Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus 2005 ·Virology ·Nico Kloosterboer,P. H. P. Groeneveld,Christine A. Jansen,(unknown),Frits Koning,(unknown),Ashley J. Duits,Frank Miedema,Debbie van Baarle,Ronald P. van Rij,Kees Brinkman,Hanneke Schuitemaker	24
19	Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma 2004 ·The Journal of Immunology ·Erwan Piriou,Karel van Dort,Nening M. Nanlohy,Frank Miedema,M. H. van Oers,Debbie van Baarle	43
20	Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes 2004 ·The Journal of Immunology ·Adrianus C. M. Boon,Gerrie de Mutsert,Debbie van Baarle,Derek J. Smith,Alan S. Lapedes,Ron A. M. Fouchier,Kees Sintnicolaas,Albert D. M. E. Osterhaus,Guus F. Rimmelzwaan	103

About Debbie van Baarle

Debbie van Baarle is a scholar working on Virology, Immunology and Infectious Diseases, having authored 131 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (53 papers), HIV Research and Treatment (34 papers) and Cytomegalovirus and herpesvirus research (34 papers). The work is most often cited by research in Virology (1.4k citations), Immunology (2.2k citations) and Infectious Diseases (970 citations). Debbie van Baarle has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Frank Miedema, Stefan Kostense, Nening M. Nanlohy, M. Shirin Sabbaghian, Stephen A. Migueles, Mark Connors, Ronald L. Rabin, Linda A. Ehler, Shuying Liu and Julia A. Metcalf. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact